RecruitingNCT07007832
Bile Omics for Diagnosing Indeterminate Biliary Strictures
Studying Adenocarcinoma of the gallbladder and extrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Principal Investigator
- Xueying Ding, MDShanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Intervention
- Endoscopic retrograde cholangiopancreatography(procedure)
- Enrollment
- 260 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, China
Collaborators
Eastern Hepatobiliary Surgery Hospital · Shanghai 6th People's Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07007832 on ClinicalTrials.govOther trials for Adenocarcinoma of the gallbladder and extrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07265674A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerJ-Pharma Co., Ltd.
- RECRUITINGPHASE3NCT06282575Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerJazz Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE1NCT03257761Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerUniversity of Southern California
See all trials for Adenocarcinoma of the gallbladder and extrahepatic biliary tract →